001     155556
005     20230915092328.0
024 7 _ |a 10.1161/STROKEAHA.120.031742
|2 doi
024 7 _ |a pmid:33940951
|2 pmid
024 7 _ |a 0039-2499
|2 ISSN
024 7 _ |a 1524-4628
|2 ISSN
024 7 _ |a altmetric:105261701
|2 altmetric
037 _ _ |a DZNE-2021-00734
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Lo, Eng H
|b 0
245 _ _ |a Circadian Biology and Stroke.
260 _ _ |a Philadelphia, Pa.
|c 2021
|b Lippincott Williams & Wilkins
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1629793357_7946
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Circadian biology modulates almost all aspects of mammalian physiology, disease, and response to therapies. Emerging data suggest that circadian biology may significantly affect the mechanisms of susceptibility, injury, recovery, and the response to therapy in stroke. In this review/perspective, we survey the accumulating literature and attempt to connect molecular, cellular, and physiological pathways in circadian biology to clinical consequences in stroke. Accounting for the complex and multifactorial effects of circadian rhythm may improve translational opportunities for stroke diagnostics and therapeutics.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|x 0
|f POF IV
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a biomarkers
|2 Other
650 _ 7 |a circadian rhythm
|2 Other
650 _ 7 |a immune system
|2 Other
650 _ 7 |a ischemia
|2 Other
650 _ 7 |a neuroprotection
|2 Other
650 _ 7 |a sleep
|2 Other
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Circadian Rhythm: physiology
|2 MeSH
650 _ 2 |a Clinical Trials as Topic: methods
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Inflammation Mediators: physiology
|2 MeSH
650 _ 2 |a Neurovascular Coupling: physiology
|2 MeSH
650 _ 2 |a Stroke: diagnosis
|2 MeSH
650 _ 2 |a Stroke: physiopathology
|2 MeSH
650 _ 2 |a Stroke: therapy
|2 MeSH
700 1 _ |a Albers, Gregory W
|b 1
700 1 _ |a Dichgans, Martin
|0 P:(DE-2719)2000030
|b 2
|u dzne
700 1 _ |a Donnan, Geoffrey
|b 3
700 1 _ |a Esposito, Elga
|b 4
700 1 _ |a Foster, Russell
|b 5
700 1 _ |a Howells, David W
|b 6
700 1 _ |a Huang, Yi-Ge
|b 7
700 1 _ |a Ji, Xunming
|b 8
700 1 _ |a Klerman, Elizabeth B
|b 9
700 1 _ |a Lee, Sarah
|b 10
700 1 _ |a Li, Wenlu
|b 11
700 1 _ |a Liebeskind, David S
|b 12
700 1 _ |a Lizasoain, Ignacio
|b 13
700 1 _ |a Mandeville, Emiri T
|b 14
700 1 _ |a Moro, Maria A
|b 15
700 1 _ |a Ning, MingMing
|b 16
700 1 _ |a Ray, David
|b 17
700 1 _ |a Sakadžić, Sava
|b 18
700 1 _ |a Saver, Jeffrey L
|b 19
700 1 _ |a Scheer, Frank A J L
|b 20
700 1 _ |a Selim, Magdy
|b 21
700 1 _ |a Tiedt, Steffen
|b 22
700 1 _ |a Zhang, Fang
|b 23
700 1 _ |a Buchan, Alastair M
|b 24
773 _ _ |a 10.1161/STROKEAHA.120.031742
|g Vol. 52, no. 6, p. 2180 - 2190
|0 PERI:(DE-600)1467823-8
|n 6
|p 2180 - 2190
|t Stroke
|v 52
|y 2021
|x 1524-4628
909 C O |o oai:pub.dzne.de:155556
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2000030
913 0 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2022-11-13
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b STROKE : 2021
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-13
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b STROKE : 2021
|d 2022-11-13
920 1 _ |0 I:(DE-2719)1111015
|k AG Höglinger 2
|l Coordinator of Clinical Parkinson Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21